Related Experiment Video

Updated: Jul 17, 2025

Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis
08:17

Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis

Published on: February 23, 2024

4.3K

Editorial: Biomarkers in autoimmune diseases of the central nervous system

Yin-Xi Zhang1, Hong-Hao Wang2, Shou-Gang Guo3

  • 1Department of Neurology, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

Frontiers in Immunology
|September 6, 2023
PubMed
Abstract

No abstract available in PubMed .

Keywords:
autoimmune diseaseautoimmune encephalitisbiomarkercentral nervous systeminflammatory demyelinating disease

More Related Videos

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.3K
Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

881

Related Experiment Videos

Last Updated: Jul 17, 2025

Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis
08:17

Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis

Published on: February 23, 2024

4.3K
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.3K
Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

881

Related Concept Videos

Autoimmune Disorders01:29

Autoimmune Disorders

492
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
492

Articles linked to this work by shared authors, journal, and citation graph.

Relapse risk and functional outcomes in anti-LGI1 encephalitis: A multicenter retrospective analysis.

Therapeutic advances in neurological disorders·2026

Real-world application of the conventional components of the 2024 McDonald diagnostic criteria for multiple sclerosis in China: a comparative study with the 2017 criteria.

Journal of neurology·2026

Astrocyte-to-microglia purinergic signaling mediates synaptic shielding and promotes neuronal activity.

bioRxiv : the preprint server for biology·2026

Microglial SWELL1 deficiency drives male-specific seizure vulnerability but paradoxical neuroprotection through impaired phagocytosis.

JCI insight·2026

Ectopic B lymphocyte follicles exacerbate ischemic brain damage via MIF-CD74/CXCR4 and interferon signaling.

The Journal of clinical investigation·2026

Microglia in Anesthesia and Perioperative Brain Health.

Glia·2026

Systemic-local immune remodeling in colorectal cancer: CD14+ cell-derived cytokine responsiveness, mucosal immune-cell organization, and exploratory metastasis-associated patterns.

Frontiers in immunology·2026

Establishment of a novel lupus mesenteric vasculitis mouse model and exploration of its exacerbation mechanisms.

Frontiers in immunology·2026

Long-term outcomes of eltrombopag plus cyclosporine A in eltrombopag-exposed patients with glucocorticoid-resistant or -dependent primary immune thrombocytopenia: a prospective, multicenter, single-arm, phase II study with extended follow-up.

Frontiers in immunology·2026

Integrating metagenomics, transcriptomics, and molecular docking to reveal core gene biomarkers and gut microbiota regulatory mechanisms in tuberculous meningitis.

Frontiers in immunology·2026

Astilbin: a novel therapeutic strategy for bone destruction in rheumatoid arthritis.

Frontiers in immunology·2026

Network biology to artificial intelligence: building the next generation of predictive drug discovery.

Frontiers in immunology·2026

Impaired regulatory T cell mediated immune tolerance promotes neurodegeneration in glaucoma.

medRxiv : the preprint server for health sciences·2026

A mouse model of myotonic dystrophy type 1 exhibits pain-like behavior and peripheral nociceptor hyperexcitability.

bioRxiv : the preprint server for biology·2026

Idiopathic axillary web syndrome as a rare cause of shoulder pain: A case report.

Turkish journal of physical medicine and rehabilitation·2026

Clinical features of concurrent systemic lupus erythematosus and renal biopsy-proven antineutrophil cytoplasmic antibody-associated vasculitis: a retrospective analysis.

Frontiers in medicine·2026

Sustained clinical stability with telitacicept-containing maintenance therapy following glucocorticoid and IVIG induction for lupus enteritis with autoimmune hemolytic anemia: a case report.

Frontiers in immunology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us